$2.85 Billion is the total value of Vivo Capital, LLC's 63 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 27.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TIL | New | Instil Bio Inc | $313,169,000 | – | 12,486,787 | +100.0% | 11.01% | – |
| ALXO | ALX Oncology Holdings Inc | $311,186,000 | -14.5% | 4,220,048 | 0.0% | 10.94% | -32.6% | |
| AMRS | Amyris, Inc | $251,391,000 | +209.3% | 13,161,847 | 0.0% | 8.84% | +143.6% | |
| ASND | Sell | Ascendis Pharma A/Ssponsored adr | $214,488,000 | -28.5% | 1,664,242 | -7.4% | 7.54% | -43.7% |
| NFH | New Frontier Health Corp | $161,590,000 | +31.4% | 14,300,000 | 0.0% | 5.68% | +3.5% | |
| HRMY | Harmony Biosciences Holdings Inc | $149,815,000 | -8.6% | 4,534,341 | 0.0% | 5.26% | -28.0% | |
| GTH | Genetron Holdings Ltdads | $136,053,000 | +53.3% | 6,339,860 | 0.0% | 4.78% | +20.7% | |
| BOLT | New | Bolt Therapeutics Inc | $127,404,000 | – | 3,871,291 | +100.0% | 4.48% | – |
| TARS | Tarsus Pharmaceuticals Inc | $104,587,000 | -22.0% | 3,245,035 | 0.0% | 3.68% | -38.6% | |
| ALGS | Aligos Therapeutics Inc | $80,659,000 | -17.8% | 3,547,030 | 0.0% | 2.84% | -35.2% | |
| LEGN | Legend Biotech Corp Sponsoredsponsored ads | $79,950,000 | +3.1% | 2,755,007 | 0.0% | 2.81% | -18.8% | |
| EPIX | Buy | Essa Pharma Inc | $60,102,000 | +166.0% | 2,068,907 | +9.2% | 2.11% | +109.5% |
| TERN | New | Terns Pharmaceuticals Inc | $58,853,000 | – | 2,675,133 | +100.0% | 2.07% | – |
| KALV | Buy | KalVista Pharmaceuticals Inc. | $47,868,000 | +55.8% | 1,863,296 | +15.1% | 1.68% | +22.7% |
| ACRS | Aclaris Therapeutics, Inc. | $41,510,000 | +289.5% | 1,647,214 | 0.0% | 1.46% | +206.5% | |
| OLMA | Olema Pharmaceuticals Inc | $41,096,000 | -31.0% | 1,238,575 | 0.0% | 1.44% | -45.7% | |
| SVA | Sinovac Biotech Ltd. | $38,173,000 | 0.0% | 5,900,000 | 0.0% | 1.34% | -21.2% | |
| ISEE | Iveric Bio Inc | $36,873,000 | -10.6% | 5,966,527 | 0.0% | 1.30% | -29.6% | |
| CRNX | Sell | Crinetics Pharmaceuticals Inc | $33,832,000 | +2.6% | 2,214,138 | -5.2% | 1.19% | -19.2% |
| SRRA | Sierra Oncology, Inc | $33,031,000 | +7.5% | 1,917,074 | 0.0% | 1.16% | -15.3% | |
| NVAX | Novavax Inc | $28,554,000 | +62.6% | 157,487 | 0.0% | 1.00% | +28.1% | |
| CLDX | Celldex Therapeutics Inc | $26,613,000 | +17.6% | 1,291,875 | 0.0% | 0.94% | -7.4% | |
| AVDL | Sell | Avadel Pharmaceuticals PLCadr | $26,551,000 | +12.7% | 2,937,093 | -16.7% | 0.93% | -11.2% |
| VRNA | Verona Pharma PLC ADRads | $25,486,000 | +19.4% | 3,048,507 | 0.0% | 0.90% | -5.9% | |
| PASG | Sell | Passage Bio Inc | $24,708,000 | -35.0% | 1,413,508 | -4.9% | 0.87% | -48.9% |
| GRCL | New | Gracell Biotechnologies Incsponsored ads | $23,454,000 | – | 1,522,994 | +100.0% | 0.82% | – |
| ZLAB | Zai Lab Ltd ADRadr | $23,350,000 | -1.4% | 175,000 | 0.0% | 0.82% | -22.3% | |
| KDMN | Kadmon Holdings Inc | $22,630,000 | -6.3% | 5,817,459 | 0.0% | 0.80% | -26.2% | |
| ARQT | Sell | Arcutis Biotherapeutics Inc | $21,535,000 | -11.7% | 744,370 | -14.2% | 0.76% | -30.5% |
| AKRO | Buy | Akero Therapeutics Inc | $19,532,000 | +19.5% | 673,280 | +6.3% | 0.69% | -5.9% |
| KDNY | Chinook Therapeutics Inc | $18,745,000 | -2.0% | 1,206,266 | 0.0% | 0.66% | -22.8% | |
| CRIS | Buy | Curis Inc | $17,586,000 | +53.4% | 1,553,500 | +11.0% | 0.62% | +20.7% |
| NKTX | Nkarta Inc | $16,852,000 | -46.5% | 512,225 | 0.0% | 0.59% | -57.9% | |
| CYTK | Cytokinetics Inc | $16,282,000 | +11.9% | 700,000 | 0.0% | 0.57% | -11.9% | |
| DSGN | New | Design Therapeutics | $15,877,000 | – | 530,991 | +100.0% | 0.56% | – |
| EIGR | Eiger BioPharmaceuticals Inc | $15,853,000 | -28.0% | 1,791,257 | 0.0% | 0.56% | -43.3% | |
| KURA | Kura Oncology Inc | $14,849,000 | -13.4% | 525,262 | 0.0% | 0.52% | -31.9% | |
| MREO | Mereo Biopharma Group PLCads | $14,225,000 | -5.9% | 4,220,938 | 0.0% | 0.50% | -25.8% | |
| LRMR | Larimar Therapeutics Inc | $11,683,000 | -31.8% | 799,662 | 0.0% | 0.41% | -46.2% | |
| CGEM | New | Cullinan Management Inc | $10,418,000 | – | 250,000 | +100.0% | 0.37% | – |
| ORTX | Orchard Therapeutics plcads | $9,625,000 | +68.1% | 1,325,736 | 0.0% | 0.34% | +32.0% | |
| ASLN | New | Aslan Pharmaceuticals Ltdads | $9,517,000 | – | 2,840,909 | +100.0% | 0.33% | – |
| ARWR | Sell | Arrowhead Pharmaceuticals Inc | $9,112,000 | -42.1% | 137,411 | -33.0% | 0.32% | -54.4% |
| ZYME | Zymeworks Inc | $9,034,000 | -33.2% | 286,064 | 0.0% | 0.32% | -47.3% | |
| DYN | Buy | Dyne Therapeutics Inc | $8,971,000 | +35.6% | 577,642 | +83.4% | 0.32% | +6.8% |
| CDXS | Codexis, Inc | $8,885,000 | +4.9% | 388,144 | 0.0% | 0.31% | -17.5% | |
| CALT | Calliditas Therapeutics ADRsponsored ads | $8,574,000 | -18.0% | 311,030 | 0.0% | 0.30% | -35.5% | |
| IMVT | Buy | Immunovant Inc | $8,547,000 | -46.8% | 532,847 | +53.3% | 0.30% | -58.2% |
| FIXX | Homology Medicines, Inc. | $8,028,000 | -16.7% | 853,143 | 0.0% | 0.28% | -34.4% | |
| STSA | New | Satsuma Pharmaceuticals Inc | $7,283,000 | – | 1,232,394 | +100.0% | 0.26% | – |
| SNDX | New | Syndax Pharmaceuticals Inc | $7,155,000 | – | 320,000 | +100.0% | 0.25% | – |
| AUPH | Aurinia Pharmaceuticals Inc. | $6,502,000 | -6.1% | 500,732 | 0.0% | 0.23% | -25.9% | |
| KALA | Kala Pharmaceuticals, Inc. | $5,304,000 | -0.6% | 786,883 | 0.0% | 0.19% | -21.8% | |
| ATRC | Atricure Inc | $4,231,000 | +17.7% | 64,573 | 0.0% | 0.15% | -6.9% | |
| MRUS | New | Merus NV | $3,656,000 | – | 175,000 | +100.0% | 0.13% | – |
| CNST | Constellation Pharmaceutical | $3,282,000 | -18.8% | 140,298 | 0.0% | 0.12% | -36.1% | |
| TXG | Sell | 10X Genomics Inc | $2,678,000 | -67.9% | 14,798 | -74.9% | 0.09% | -74.8% |
| ZGNX | Sell | Zogenix Inc | $2,050,000 | -89.8% | 105,000 | -89.6% | 0.07% | -92.0% |
| VYNE | Sell | VYNE Therapeutics Inc | $1,608,000 | +8.4% | 234,877 | -75.0% | 0.06% | -13.6% |
| IGMS | IGM Biosciences Inc | $1,534,000 | -13.1% | 20,000 | 0.0% | 0.05% | -31.6% | |
| DTIL | Precision Biosciences Inc | $1,452,000 | +24.1% | 140,255 | 0.0% | 0.05% | -1.9% | |
| MTCR | Metacrine Inc | $908,000 | -21.1% | 146,426 | 0.0% | 0.03% | -37.3% | |
| TCDA | Tricida, Inc. | $924,000 | -25.0% | 174,763 | 0.0% | 0.03% | -41.8% | |
| RVMD | Exit | Revolution Medicines Inc | $0 | – | -16,690 | -100.0% | -0.03% | – |
| OVID | Exit | Ovid Therapeutics Inc | $0 | – | -1,250,000 | -100.0% | -0.13% | – |
| CBAY | Exit | Cymabay Therapeutics Inc | $0 | – | -585,394 | -100.0% | -0.15% | – |
| MTNB | Exit | Matinas Biopharma Hldgs Inc | $0 | – | -6,451,612 | -100.0% | -0.39% | – |
| PSTX | Exit | Poseida Therapeutics Inc | $0 | – | -926,447 | -100.0% | -0.45% | – |
| RCKT | Exit | Rocket Pharmaceuticals Inc | $0 | – | -310,584 | -100.0% | -0.76% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
| CODEXIS INC | 29 | Q3 2023 | 8.0% |
| ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
| KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
| Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
| AMYRIS INC | 23 | Q3 2023 | 8.8% |
| EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
| Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
| Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
| HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-22 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.